BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 6753801)

  • 21. Hemodynamic effects of once a day administration of combined chlorthalidone and metoprolol slow-release in essential hypertension.
    Pomidossi G; Parati G; Motolese M; Mancia G; Zanchetti A
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):665-71. PubMed ID: 6526542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Atenolol and metoprolol in the treatment of slight to moderate hypertension. A comparative study].
    Rasmussen S; Arnung K; Eskildsen PC; Nielsen PE
    Ugeskr Laeger; 1982 Dec; 144(51):2823-6. PubMed ID: 6762745
    [No Abstract]   [Full Text] [Related]  

  • 23. [Multicenter study with a fixed combination of oxprenolol/chlorthalidone in essential arterial hypertension].
    Albanesi Filho FM; Benchimol AB
    Arq Bras Cardiol; 1980 May; 34(5):409-14. PubMed ID: 7006573
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative study of hydrochlorothiazide and a fixed combination of metoprolol and hydrochlorothiazide essential hypertension.
    Dafgärd T; Forsén B; Lindahl T
    Ann Clin Res; 1981; 13 Suppl 30():37-44. PubMed ID: 7027892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic effects of cadralazine or chlorthalidone in verapamil-treated elderly hypertensives.
    Antonicelli R; Savonitto S; Tomassini PF; Gambini C; Sardina M; Paciaroni E
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):198-203. PubMed ID: 8032580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metoprolol in hypertension: an open evaluation.
    Assaykeen TA; Michell G
    Med J Aust; 1982 Jan; 1(2):73-7. PubMed ID: 7040924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Controlled study of the antihypertensive effects of the combination of metoprolol and chlorthalidone].
    Albertazzi A; Del Rosso G; Cappelli P
    G Clin Med; 1983; 64(3-4):124-30. PubMed ID: 6884639
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical, ergometric and polygraphic evaluation of the effects of metoprolol and labetalol administration in essential arterial hypertension. Comparative study].
    Schirripa V; Attisano N; Sarica G; Grenci G; Martelli G
    Minerva Med; 1982 Apr; 73(14):845-9. PubMed ID: 7070696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical and polygraphic evaluation of the effects of metoprolol and labetalol in essential arterial hypertension. Comparative study].
    Schirripa V; Attisano N; Sarica G; Grenci G; Martelli G
    Boll Soc Ital Cardiol; 1981; 26(11):1909-16. PubMed ID: 7349263
    [No Abstract]   [Full Text] [Related]  

  • 30. [Controlled study of antihypertensive effects of indapamide and metoprolol and their combination in patients with essential arterial hypertension].
    Novo S; Licata G; Pinto A; Davì G; Pepe S; Di Vitale P; Mannino V; Strano A
    Cardiologia; 1982; 27(8):765-88. PubMed ID: 6765445
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-acting beta-blockers in the twenty-fourth hour. A comparison in hypertension.
    Hackett GI; Harrison P; Kershaw S
    Practitioner; 1981 May; 225(1355):752-5. PubMed ID: 7027230
    [No Abstract]   [Full Text] [Related]  

  • 32. An evaluation of the effect on resting and exercise blood pressure of some first line treatments in hypertension.
    Lorimer AR; Barbour MB; Lawrie TD
    Ann Clin Res; 1983; 15(1):30-4. PubMed ID: 6859790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Use of metoprolol and atenolol, singly or in combination with a diuretic, in the treatment of arterial hypertension].
    Centritto V
    Boll Soc Ital Cardiol; 1980; 25(5):451-7. PubMed ID: 7284149
    [No Abstract]   [Full Text] [Related]  

  • 34. [Non-invasive evaluation of some hemodynamic effects of metoprolol].
    Saettone G; Muzio L
    Boll Soc Ital Cardiol; 1981; 26(12):2119-21. PubMed ID: 7185378
    [No Abstract]   [Full Text] [Related]  

  • 35. A controlled evaluation of metoprolol.
    Woollard KV; Harris AM
    Practitioner; 1978 Dec; 221(1326):941-3. PubMed ID: 372937
    [No Abstract]   [Full Text] [Related]  

  • 36. [New selective beta 1-receptor antagonist. A comparison of metoprolol (Seloken) and placebo in mild to moderate hypertension].
    Andreassen PH; Drivenes A
    Tidsskr Nor Laegeforen; 1977 Aug; 97(22):1081-3, 78. PubMed ID: 333653
    [No Abstract]   [Full Text] [Related]  

  • 37. Chlorthalidone alone or in fixed combination with slow-release metoprolol in the management of arterial hypertension: a long-term study of 545 patients.
    Bichisao E; Merlini L; Gambini O; Alberti D; Pollavini G
    J Int Med Res; 1989; 17(4):339-49. PubMed ID: 2676651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of antihypertensive medications in office and ambulatory settings: a placebo-controlled comparison of atenolol, metoprolol, chlorthalidone, verapamil, and an atenolol-chlorthalidone combination.
    Durel LA; Hayashi PJ; Weidler DJ; Schneiderman N
    J Clin Pharmacol; 1992 Jun; 32(6):564-70. PubMed ID: 1634645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of a calcium antagonist, verapamil, on mild-moderate essential arterial hypertension].
    Hergueta García de Guadiana G; Paumard Fraguas A
    An Med Interna; 1989 Jan; 6(1):15-8. PubMed ID: 2491026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metoprolol in the long-term treatment of hypertension.
    Comerford MB; Pringle A
    Practitioner; 1976 Dec; 217(1302):953-7. PubMed ID: 796841
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.